Diazyme Laboratories Is Granted Summary Judgment of Noninfringement Regarding Homocysteine Assay Patents
24 July 2006 The United States District Court for the Northern District of California ruled on Wednesday that Diazyme Laboratories' enzymatic homocysteine assay does not infringe two U.S. patents held by Axis-Shield, ASA, a Norwegian company. The Court held that none of the claims of either of the two patents in the case cover Diazyme's assay. The ruling was reached after extensive briefing and a full hearing on the technical nature of the claims. The Court's complete order can be downloaded at www.diazyme.com/order.pdf.
Diazyme Laboratories, a life sciences division of General Atomics, filed the action for declaratory relief against Axis-Shield in October, 2005. Diazyme challenged patents involving homocysteine assay technology in order to protect its homocysteine enzymatic assay which can be used on most automated chemistry analyzers. Additionally, on February 8, 2006, the United States Patent and Trademark Office issued a Notice of Allowance of General Atomics' patent application on this technology.
For Further Information Contact:
Diazyme Laboratories: Chong Yuan (858) 455-4760 Email Contact
Public Relations: Doug Fouquet (858) 455-2173 Email Contact
SOURCE: General Atomics
Source: marketwire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|
